Michael Man

1.4k total citations
23 papers, 1.0k citations indexed

About

Michael Man is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michael Man has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Michael Man's work include Gene expression and cancer classification (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Molecular Biology Techniques and Applications (4 papers). Michael Man is often cited by papers focused on Gene expression and cancer classification (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Molecular Biology Techniques and Applications (4 papers). Michael Man collaborates with scholars based in United States, Italy and France. Michael Man's co-authors include Yixin Wang, Xuning Wang, Wei‐Yin Loh, Xu He, Shawn T. Estrem, Karim A. Benhadji, Sandra Close, Stephen D. Wise, Shin Irie and Carmen M. Dumaual and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

Michael Man

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Man United States 16 383 343 133 117 107 23 1.0k
Olivier Grenet Switzerland 15 550 1.4× 223 0.7× 134 1.0× 160 1.4× 102 1.0× 27 1.1k
Mark Penney United Kingdom 15 507 1.3× 75 0.2× 207 1.6× 82 0.7× 76 0.7× 18 1.1k
Christina R. Chow United States 15 428 1.1× 150 0.4× 56 0.4× 64 0.5× 85 0.8× 29 773
Diane D. Wang United States 14 191 0.5× 372 1.1× 126 0.9× 48 0.4× 29 0.3× 29 825
Jürgen Dippon Germany 13 274 0.7× 359 1.0× 29 0.2× 89 0.8× 33 0.3× 34 765
Anja Henningsson Sweden 8 197 0.5× 567 1.7× 45 0.3× 69 0.6× 20 0.2× 12 889
Stephen J. Iturria United States 15 276 0.7× 179 0.5× 77 0.6× 68 0.6× 506 4.7× 23 1.2k
Kirill Peskov Russia 16 283 0.7× 218 0.6× 109 0.8× 41 0.4× 22 0.2× 54 697
Nathalie Gérard France 21 304 0.8× 219 0.6× 221 1.7× 59 0.5× 66 0.6× 58 1.3k
Dennie V. Jones United States 19 493 1.3× 530 1.5× 64 0.5× 117 1.0× 55 0.5× 59 1.3k

Countries citing papers authored by Michael Man

Since Specialization
Citations

This map shows the geographic impact of Michael Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Man more than expected).

Fields of papers citing papers by Michael Man

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Man. The network helps show where Michael Man may publish in the future.

Co-authorship network of co-authors of Michael Man

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Man. A scholar is included among the top collaborators of Michael Man based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Man. Michael Man is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nadal, Ernest, Mansoor N. Saleh, Santiago Ponce Aix, et al.. (2023). A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer. BMC Cancer. 23(1). 708–708. 36 indexed citations
2.
Melisi, Davide, Do‐Youn Oh, Antoine Hollebecque, et al.. (2021). Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer. Journal for ImmunoTherapy of Cancer. 9(3). e002068–e002068. 149 indexed citations
3.
Giannelli, Gianluigi, Armando Santoro, Robin Kate Kelley, et al.. (2021). Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. PLoS ONE. 16(6). e0253671–e0253671. 2 indexed citations
4.
Giannelli, Gianluigi, Armando Santoro, Robin Kate Kelley, et al.. (2020). Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. PLoS ONE. 15(3). e0222259–e0222259. 46 indexed citations
5.
6.
Melisi, Davide, Rocio García‐Carbonero, Teresa Macarulla, et al.. (2019). TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer. Cancer Chemotherapy and Pharmacology. 83(5). 975–991. 77 indexed citations
7.
Giles, Brendan M., Karim A. Benhadji, Boris K. Lin, et al.. (2018). Analytical Characterization of an Enzyme-Linked Immunosorbent Assay for the Measurement of Transforming Growth Factor β1 in Human Plasma. The Journal of Applied Laboratory Medicine. 3(2). 200–212. 4 indexed citations
8.
Loh, Wei‐Yin, et al.. (2018). Subgroups from regression trees with adjustment for prognostic effects and postselection inference. Statistics in Medicine. 38(4). 545–557. 6 indexed citations
9.
Nasir, Aejaz, et al.. (2017). Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies. Cancer Cell International. 17(1). 56–56. 25 indexed citations
10.
Loh, Wei‐Yin, Haoda Fu, Michael Man, Victoria L. Champion, & Menggang Yu. (2016). Identification of subgroups with differential treatment effects for longitudinal and multiresponse variables. Statistics in Medicine. 35(26). 4837–4855. 16 indexed citations
11.
Close, Sandra, Michael Man, Scott S. Sundseth, et al.. (2015). PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes. Journal of Thrombosis and Thrombolysis. 41(3). 374–383. 22 indexed citations
12.
Guennel, Tobias, et al.. (2013). Estimating heritability in Pharmacogenetic Studies. Pharmacogenomics. 14(4). 369–377. 7 indexed citations
13.
Mega, Jessica L., Sandra Close, Stephen D. Wiviott, et al.. (2011). Abstract 11255: PON1 Q192R (rs662) Genetic Variant and Response to Clopidogrel and Prasugrel. Circulation. 124. 101–12. 1 indexed citations
14.
Man, Michael, Mark W. Farmen, Carmen M. Dumaual, et al.. (2010). Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans. The Journal of Clinical Pharmacology. 50(8). 929–940. 170 indexed citations
15.
Cox, Melissa L., et al.. (2007). Investigating fixative-induced changes in RNA quality and utility by microarray analysis. Experimental and Molecular Pathology. 84(2). 156–172. 30 indexed citations
16.
Peterkin, Vincent, Jonathan Bauman, Theunis C. Goosen, et al.. (2007). Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes. British Journal of Clinical Pharmacology. 64(4). 458–468. 46 indexed citations
17.
Man, Michael, et al.. (2006). Optimal two-stage strategy for detecting interacting genes in complex diseases. BMC Genetics. 7(1). 39–39. 20 indexed citations
18.
Man, Michael, et al.. (2004). The influence of tumor size and environment on gene expression in commonly used human tumor lines. BMC Cancer. 4(1). 35–35. 12 indexed citations
19.
Man, Michael, et al.. (2002). Expression profiling of human renal carcinomas with functional taxonomic analysis. BMC Bioinformatics. 3(1). 26–26. 41 indexed citations
20.
Man, Michael, Xuning Wang, & Yixin Wang. (2000). POWER_SAGE: comparing statistical tests for SAGE experiments. Bioinformatics. 16(11). 953–959. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Grenet Breakdown of academic impact, for papers by Mark Penney Breakdown of academic impact, for papers by Christina R. Chow Breakdown of academic impact, for papers by Diane D. Wang Breakdown of academic impact, for papers by Jürgen Dippon Breakdown of academic impact, for papers by Anja Henningsson Breakdown of academic impact, for papers by Stephen J. Iturria Breakdown of academic impact, for papers by Kirill Peskov Breakdown of academic impact, for papers by Nathalie Gérard Breakdown of academic impact, for papers by Dennie V. Jones
Rankless by CCL
2026